Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel TRPC5 inhibitors show potential for the treatment of CKD

May 3, 2022

Ring Therapeutics describes in vitro system enabling human anellovirus production

May 3, 2022

ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo

May 3, 2022

Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies

May 3, 2022

Hemispherian closes seed funding to advance preclinical pipeline for cancer

May 3, 2022

Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif

May 3, 2022

S trimer-engaging multivalent protein neutralizes SARS-CoV-2 variants and protects mice

May 3, 2022

Allogeneic colorectal cancer vaccine active against anti-PD-1-resistant colon cancer

May 3, 2022

Serine/threonine-protein kinase Pim-1 inhibitors identified at Japan Tobacco

May 3, 2022

Lilly patents dopamine D1 receptor positive allosteric modulators

May 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...